Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 4
2005 5
2006 12
2007 11
2008 14
2009 13
2010 4
2011 14
2012 10
2013 14
2014 10
2015 7
2016 10
2017 6
2018 12
2019 14
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

143 results
Results by year
Filters applied: . Clear all
Page 1
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032.
Ready N, Farago AF, de Braud F, Atmaca A, Hellmann MD, Schneider JG, Spigel DR, Moreno V, Chau I, Hann CL, Eder JP, Steele NL, Pieters A, Fairchild J, Antonia SJ. Ready N, et al. Among authors: atmaca a. J Thorac Oncol. 2019 Feb;14(2):237-244. doi: 10.1016/j.jtho.2018.10.003. Epub 2018 Oct 10. J Thorac Oncol. 2019. PMID: 30316010 Free article. Clinical Trial.
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ. Hellmann MD, et al. Among authors: atmaca a. Cancer Cell. 2018 May 14;33(5):853-861.e4. doi: 10.1016/j.ccell.2018.04.001. Epub 2018 May 3. Cancer Cell. 2018. PMID: 29731394 Free PMC article.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E. Antonia SJ, et al. Among authors: atmaca a. Lancet Oncol. 2016 Jul;17(7):883-895. doi: 10.1016/S1470-2045(16)30098-5. Epub 2016 Jun 4. Lancet Oncol. 2016. PMID: 27269741 Clinical Trial.
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort.
Ready NE, Ott PA, Hellmann MD, Zugazagoitia J, Hann CL, de Braud F, Antonia SJ, Ascierto PA, Moreno V, Atmaca A, Salvagni S, Taylor M, Amin A, Camidge DR, Horn L, Calvo E, Li A, Lin WH, Callahan MK, Spigel DR. Ready NE, et al. Among authors: atmaca a. J Thorac Oncol. 2020 Mar;15(3):426-435. doi: 10.1016/j.jtho.2019.10.004. Epub 2019 Oct 17. J Thorac Oncol. 2020. PMID: 31629915 Free article.
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E; Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE, et al. Among authors: atmaca a. J Clin Oncol. 2008 Mar 20;26(9):1435-42. doi: 10.1200/JCO.2007.13.9378. J Clin Oncol. 2008. PMID: 18349393 Clinical Trial.
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Hofheinz R, Homann N, Rethwisch V, Probst S, Stoehlmacher J, Clemens MR, Mahlberg R, Fritz M, Seipelt G, Sievert M, Pauligk C, Atmaca A, Jäger E. Al-Batran SE, et al. Among authors: atmaca a. Ann Oncol. 2008 Nov;19(11):1882-7. doi: 10.1093/annonc/mdn403. Epub 2008 Jul 31. Ann Oncol. 2008. PMID: 18669868 Free article. Clinical Trial.
Distribution of psychogenic and vascular impotence in a tertiary health-care center's cohort: A retrospective study using penile Doppler imaging.
Gok B, Hamidi N, Cakici OU, Koc E, Kamaci D, Asil E, Keske M, Ozcan AN, Atmaca AF. Gok B, et al. Among authors: atmaca af. Rev Int Androl. 2020 Jul-Sep;18(3):91-95. doi: 10.1016/j.androl.2019.01.002. Epub 2019 Jul 2. Rev Int Androl. 2020. PMID: 31272908
In vitro cytogenetic assessment and comparison of vildagliptin and sitagliptin.
Börçek Kasurka C, Elbistan M, Atmaca A, Atlı Şekeroğlu Z. Börçek Kasurka C, et al. Among authors: atmaca a. Cytotechnology. 2019 Dec;71(6):1063-1077. doi: 10.1007/s10616-019-00345-y. Epub 2019 Sep 25. Cytotechnology. 2019. PMID: 31555935 Free PMC article.
Management of ureteric duplications identified during robotic cystectomy and intracorporeal urinary diversion.
Koç E, Atmaca AF, Asil E, Gok B, Canda AE, Balbay MD. Koç E, et al. Among authors: atmaca af. Minerva Urol Nefrol. 2018 Oct;70(5):534-537. doi: 10.23736/S0393-2249.18.03136-3. Epub 2018 Jul 3. Minerva Urol Nefrol. 2018. PMID: 29969001
Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery.
Ecemis GC, Atmaca A, Meydan D. Ecemis GC, et al. Among authors: atmaca a. Expert Rev Neurother. 2013 May;13(5):557-65. doi: 10.1586/ern.13.37. Expert Rev Neurother. 2013. PMID: 23621312 Review.
143 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback